Skip to main content
Clinical Trials/NCT04260776
NCT04260776
Withdrawn
Phase 1

A SMART Pilot of Adaptive Treatment Strategies to Improve Engagement With a Web-Based Intervention for Socially Anxious Smokers

Fred Hutchinson Cancer Center1 site in 1 countryApril 15, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Social Anxiety Disorder
Sponsor
Fred Hutchinson Cancer Center
Locations
1
Primary Endpoint
Utilization of Phase 1 text messages
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This phase I trial will use a pilot sequential multiple assignment randomized trial (SMART) to examine protocol feasibility and acceptability of new components of a web-based intervention for socially anxious smokers. This study will be used to help build an adaptive treatment strategy to improve engagement with and effectiveness of the web-based intervention. Adaptive treatment strategies provide individualized sequences of intervention components to accommodate the changing needs of individuals based on their characteristics, treatment response, or engagement.

Detailed Description

This study proposes to use a pilot SMART to help build an adaptive treatment strategy to improve engagement with and effectiveness of a web-based intervention for socially anxious smokers. At the outset of the study (Phase 1), participants will receive access to a new web-based smoking intervention (MyWebQuit) and will randomized to receive one of two text message services: 1) 1-way text messages, or 2) interactive, 2-way text messages. Those who disengage with the website in the first 5 weeks will be re-randomized to one of three re-engagement strategies: 1) re-engagement emails, 2) re-engagement interactive text messages, or 3) no re-engagement strategy. Outcomes include protocol feasibility, treatment acceptability, treatment utilization, and smoking cessation.

Registry
clinicaltrials.gov
Start Date
April 15, 2022
End Date
December 31, 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • resides in the US and anticipates remaining in the US for the duration of the study
  • smokes at least 5 cigarettes per day for at least 12 months prior to screening
  • desire to quit smoking within 30 days
  • has at least weekly internet access
  • current use of a personal email account
  • current use of text messaging
  • willing to receive text messages as part of this study
  • screen positive for social anxiety (LSAS-SR ≥ 60)
  • interested in participating in the study for themselves (versus \[vs\] someone else)
  • not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Utilization of Phase 1 text messages

Time Frame: 3 months

Proportion of participants who unsubscribe from the Phase 1 text messages

Website Utilization

Time Frame: 3 months

Percent of participants who login after rerandomization

Recruitment

Time Frame: Recruitment

Number of individuals screened, eligible, consented; reasons for ineligibility

Data retention

Time Frame: 3 months

Percentage of participants who complete outcome assessment at 3-months

Acceptability of intervention and Phase 2 engagement components

Time Frame: 3 months

Treatment satisfaction ratings of the Phase 2 treatment conditions

Utilization of interactive messages

Time Frame: 3 months

Proportion of interactive text message prompts participants respond to

Acceptability of intervention and Phase 1 engagement components

Time Frame: 3 months

Treatment satisfaction ratings of the Phase 1 treatment conditions.

Secondary Outcomes

  • Biochemically confirmed smoking abstinence(3 months)
  • Self-reported 7-day point prevalence abstinence(3 months)
  • Self-reported 30-day point prevalence abstinence(3 months)

Study Sites (1)

Loading locations...

Similar Trials